Tebipenem pivoxil(L-084) loperastine Fendizoate InChi: InChI=1S/C26H35N3O11/c30-21-5-4-20(24(33)28-21)29-25(34)18-2-1-3-19(23(18)26(29)35)27-7-9-37-11-13-39-15-17-40-16-14-38-12-10-36-8-6-22(31)32/h1-3

InChi: InChI=1S/C26H35N3O11/c30-21-5-4-20(24(33)28-21)29-25(34)18-2-1-3-19(23(18)26(29)35)27-7-9-37-11-13-39-15-17-40-16-14-38-12-10-36-8-6-22(31)32/h1-3

32)33)23(29)19(21)13-17-5-7-18(8-6-17)14-20-22-10-12-28(24(20)30

Trifluridine/tipiracil hydrochloride

It thus produces an antipyretic action without causing gastric injury

48 and 72 h of treatment with 0

Tebipenem pivoxil(L-084) loperastine Fendizoate InChi: InChI=1S/C26H35N3O11/c30-21-5-4-20(24(33)28-21)29-25(34)18-2-1-3-19(23(18)26(29)35)27-7-9-37-11-13-39-15-17-40-16-14-38-12-10-36-8-6-22(31)32/h1-3Tebipenem Pivoxil is a novel oral carbapenem antibiotic. Target: Antibacterial Tebipenem is a broad spectrum orally administered antibiotic, from the carbapenem subgroup of beta lactam antibiotics. It was developed as a replacement drug to combat bacteria that had acquired antibiotic resistance to commonly used antibiotics. Tebipenem is formulated as the ester tebipenem pivoxil due to the better absorption and improved bioavailability of this form. It